Five professional gastroenterology organizations caution that more data are needed to understand if and when GLP-1 receptor agonists should be held prior to elective endoscopy.
Our July 2023 endocrinology month in review features an FDA approval, topline results from a pair of major trials, and a pair of new guidelines related to the management and diagnosis of diabetes.
With the popularity of the class skyrocketing, the American Society of Anesthesiologists has released new guidance urging patients to withhold GLP-1 receptor agonist use prior to elective surgeries or procedures based on potential risk of regurgitation and aspiration associated with delayed gastric emptying.
People taking Ozempic, Wegovy, or other GLP-1 antagonists should stop taking the medications before surgery, according to new recommendation from the American Society of Anesthesiologists.